Best General Drug Manufacturer Stocks to Buy Now (2025)Top general drug manufacturer stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 5th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | $94.60B | 34.70% | 6.40% | 11.67% | 13.00% | 4.22 | 1.27 | 69.50% | 12.60% | 16.71% | ||
| LLY | ELI LILLY & CO | $875.25B | 102.30% | 19.20% | 30.09% | 27.00% | 3.83 | 1.55 | 83.00% | 31.00% | 37.87% | ||
| GSK | GSK PLC | $94.17B | 37.40% | 9.10% | 17.83% | 23.80% | 2.82 | 0.84 | 72.30% | 17.10% | 22.17% | ||
| AMRN | AMARIN CORP PLC | $318.34M | -18.30% | -12.90% | -17.45% | -23.50% | 0.44 | 3.45 | 38.90% | -38.00% | -36.76% | ||
| ABBV | ABBVIE INC | $383.12B | 497.50% | 1.80% | 4.48% | 6.30% | -51.66 | 0.73 | 69.70% | 4.00% | 7.10% | ||
| GRFS | GRIFOLS SA | $5.93B | 2.70% | 0.70% | 5.73% | 5.80% | 2.18 | 2.66 | 38.70% | 2.20% | 15.29% | ||
| JNJ | JOHNSON & JOHNSON | $448.13B | 32.70% | 13.20% | 22.82% | 47.00% | 1.43 | 1.07 | 68.10% | 27.30% | 35.16% | ||
| GILD | GILEAD SCIENCES INC | $152.10B | 32.90% | 11.20% | 18.42% | 23.70% | 1.84 | 1.32 | 78.50% | 21.90% | 28.42% | ||
| AZN | ASTRAZENECA PLC | $251.57B | 19.80% | 7.80% | 14.82% | 26.20% | 1.51 | 0.86 | 81.40% | 14.70% | 20.68% | ||
| SNY | SANOFI | $123.79B | 12.80% | 7.20% | 11.91% | 27.80% | 0.78 | 1.27 | 71.60% | 21.20% | 26.49% | ||
| SCLX | SCILEX HOLDING CO | $128.47M | N/A | -138.10% | 32.94% | 40.80% | -1.34 | 0.11 | 70.40% | -278.00% | -165.46% | ||
| MRK | MERCK & CO INC | $210.79B | 34.90% | 14.00% | 22.33% | 26.50% | 1.40 | 1.42 | 76.60% | 25.80% | 32.11% | ||
| NVS | NOVARTIS AG | $241.71B | 34.10% | 13.90% | 23.30% | 41.50% | 1.41 | 0.88 | 76.20% | 25.50% | 31.12% | ||
| AMGN | AMGEN INC | $172.24B | 96.20% | 7.80% | 16.23% | 15.60% | 8.37 | 1.28 | 66.20% | 19.50% | 30.84% | ||
| PFE | PFIZER INC | $139.93B | 10.90% | 4.70% | 5.31% | 8.30% | 1.25 | 1.28 | 73.40% | 15.70% | 14.56% | ||
| BIIB | BIOGEN INC | $22.51B | 9.30% | 5.70% | 7.35% | 16.20% | 0.60 | 2.72 | 75.20% | 16.00% | 18.92% | ||
| OGN | ORGANON & CO | $1.66B | 125.00% | 5.30% | 11.01% | 9.30% | 17.42 | 1.65 | 56.30% | 11.10% | 18.77% | ||
| MIRA | MIRA PHARMACEUTICALS INC | $29.18M | -406.70% | -328.40% | -1,375.94% | 2,456.50% | 0.52 | 2.79 | N/A | N/A | N/A | ||
| MDCX | MEDICUS PHARMA LTD | $40.98M | -549.40% | -228.10% | -491.82% | 1,512.90% | 2.67 | 1.29 | N/A | N/A | N/A | ||
| NSRX | NASUS PHARMA LTD | N/A | N/A | N/A | 46.79% | N/A | -1.22 | 0.12 | N/A | N/A | N/A |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.